- Home
- BNR vs FTHM Comparison
BNR vs FTHM Comparison
Compare BNR & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- FTHM
- Stock Information
- Founded
- BNR 2014
- FTHM 2010
- Country
- BNR China
- FTHM United States
- Employees
- BNR N/A
- FTHM N/A
- Industry
- BNR Medical Specialities
- FTHM Real Estate
- Sector
- BNR Health Care
- FTHM Finance
- Exchange
- BNR Nasdaq
- FTHM Nasdaq
- Market Cap
- BNR 29.1M
- FTHM 33.6M
- IPO Year
- BNR 2020
- FTHM 2020
- Fundamental
- Price
- BNR $3.23
- FTHM $1.46
- Analyst Decision
- BNR
- FTHM Buy
- Analyst Count
- BNR 0
- FTHM 1
- Target Price
- BNR N/A
- FTHM $2.50
- AVG Volume (30 Days)
- BNR 38.7K
- FTHM 72.7K
- Earning Date
- BNR 06-06-2025
- FTHM 08-11-2025
- Dividend Yield
- BNR N/A
- FTHM N/A
- EPS Growth
- BNR N/A
- FTHM N/A
- EPS
- BNR N/A
- FTHM N/A
- Revenue
- BNR $72,112,038.00
- FTHM $357,816,000.00
- Revenue This Year
- BNR $136.32
- FTHM $32.40
- Revenue Next Year
- BNR N/A
- FTHM $18.04
- P/E Ratio
- BNR N/A
- FTHM N/A
- Revenue Growth
- BNR 0.53
- FTHM 5.80
- 52 Week Low
- BNR $2.18
- FTHM $0.65
- 52 Week High
- BNR $7.90
- FTHM $3.37
- Technical
- Relative Strength Index (RSI)
- BNR 49.06
- FTHM 69.52
- Support Level
- BNR $3.06
- FTHM $1.24
- Resistance Level
- BNR $3.50
- FTHM $1.36
- Average True Range (ATR)
- BNR 0.36
- FTHM 0.10
- MACD
- BNR -0.04
- FTHM 0.03
- Stochastic Oscillator
- BNR 15.79
- FTHM 98.08
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.